Abstract
(Anesth Analg. 2019;129(2):387–396) Postoperative pain management is a challenge, with only 1 in 4 surgical patients in the United States reporting adequate pain relief. This can lead to unwanted consequences, such as excessive analgesic use. The authors of this study recently developed new liposomal delivery models for ropivacaine (RVC), and they sought to assess these formulations for postoperative pain control in animal models.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
